Tempus (IPO)

Funding Details
Awarder
Inbox
Date Award
June 14, 2024
Vertical
Genomic testing and data analysis
Funding URL
View Funding Page
Valuation
$6,000,000

Company Info
Founding Year
2015
Traction
Tempus had revenues of $531 million in 2023 with a net loss of $290 million. The company's operating losses have decreased from 83% in 2022 to 37% in 2023.
Revenue Amount
$531,000,000
Organizations Involved
NEA, Revolution, T. Rowe Price, SoftBank
Founders
Eric Lefkofsky
Company Description
Tempus is a genomic testing and data analysis company founded by Eric Lefkofsky, who previously founded Groupon. The company aims to leverage technology and data derived from genomic sequencing to improve healthcare.
Market
Health tech
Location
US
Coinvestors
NEA, Revolution, T. Rowe Price, SoftBank

Links
Back to Home Back to Genomic testing and data analysis Deals View Funding Announcement